News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Aaron Goodman Highlights IL18-Secreting CAR T Therapy for Refractory Lymphoma
Aaron Goodman/X
May 9, 2025, 12:28

Aaron Goodman Highlights IL18-Secreting CAR T Therapy for Refractory Lymphoma

Aaron Goodman, Hematologist/Oncologist and an Associate Professor of Medicine at the University of California, shared a post on X:

“This is pretty cool and amazing! Anti-CD19 CART that secretes IL18. 3-day manufacturing process! 50% durable CR in patients with refractory lymphoma who had prior anti-CD19 CAR T. Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure | NEJM.”

Title: Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure

Authors: Jakub Svoboda, Daniel J. Landsburg, James Gerson, Sunita D. Nasta, Stefan K. Barta, Elise A. Chong, Michael Cook, Noelle V. Frey, Joanne Shea, Amanda Cervini, Amy Marshall, Megan Four, Megan M. Davis, Julie K. Jadlowsky, Anne Chew, Edward Pequignot, Vanessa Gonzalez, Julia Han Noll, Luca Paruzzo, Juliana Rojas-Levine, Gabriela Plesa, John Scholler, Donald L. Siegel, Bruce L. Levine, David L. Porter, Saba Ghassemi, Marco Ruella, Andrew Rech, Rachel M. Leskowitz, Joseph A. Fraietta, Wei-Ting Hwang, Elizabeth Hexner, Stephen J. Schuster, Carl H. June

Aaron Goodman Highlights IL18-Secreting CAR T Therapy for Refractory Lymphoma

Read the Full Article on NEJM.

More posts featuring Aaron Goodman.

Aaron Goodman Amanda Cervini Amy Marshall Andrew Rech Anne Chew Bruce L. Levine cancer CAR T-cell therapy Carl H. June Daniel J. Landsburg David L. Porter Donald L. Siegel Edward Pequignot Elise A. Chong Elizabeth Hexner Gabriela Plesa Jakub Svoboda James Gerson Joanne Shea John Scholler Joseph A. Fraietta Julia Han Noll Juliana Rojas-Levine Julie K. Jadlowsky Luca Paruzzo lymphoma Marco Ruella Megan Four Megan M. Davis Michael Cook NEJM Noelle V. Frey OncoDaily Oncology Rachel M. Leskowitz Saba Ghassemi Stefan K. Barta Stephen J. Schuster Sunita D. Nasta Vanessa Gonzalez Wei-Ting Hwang
Special Coverage
Blog
Jul 9, 2025, 21:20
Herbert Loong: Sarcomas Are a Group of Rare Diseases Which Benefits From Awareness and Specialist Care
Opinion
Jul 9, 2025, 21:08
Paolo Tarantino Opens the 3rd Annual ADC Toxicity Summit
Insight
Jul 9, 2025, 21:02
Marianna Vitaloni: I'm Incredibly Grateful to the Patients Who Shared Their Stories With Us
Blog
Jul 9, 2025, 20:28
Jennifer Guida: I Had the Privilege to Lead Pioneering Work at the NCI Focused on Cancer Survivorship, Healthy Aging, and Resilience
Blog
Jul 9, 2025, 20:10
Every Person Living with NCDs Such as Cancer Has Access to the Treatment and Care They Need - UICC
Blog
Jul 9, 2025, 19:55
Erythropoietin Promotes an Immunosuppressive Tumor Microenvironment in Liver Cancer Models - NCI Division of Cancer Biology
Blog
Jul 9, 2025, 19:35
UF Health Cancer Center Welcomed Nearly 150 Middle and High School Science Teachers From Across the Southeast
Blog
Jul 9, 2025, 19:16
SIOP Provides Scholarships to Nurses Who Have Insufficient Resources to Participate and to Travel to Our Congress
Blog
Jul 9, 2025, 18:36
2nd Synergies Forum Marks Milestone for Pediatric and Young Adult Cancer Advocacy in Europe - ELLOK
Insight
Jul 9, 2025, 18:16
Akhil Kapoor: We Acknowledge and Appreciate the Trial’s Bold and Innovative Approach in Challenging Established Treatment Paradigms
Blog
Jul 9, 2025, 17:59
Afreen Shariff: Ready to Take Cancer Care to New Heights?
Blog
Jul 9, 2025, 17:48
Adrian Pogacian: New Developments in Scanxiety Live Webinar